Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Adjuvant TNF-a therapy to electrochemotherapy with intravenous cisplatin in murine sarcoma exerts synergistic antitumor effectiveness
Avtorji:ID Čemažar, Maja (Avtor)
ID Todorović, Vesna (Avtor)
ID Ščančar, Janez (Avtor)
ID Lampreht Tratar, Urša (Avtor)
ID Savarin, Monika (Avtor)
ID Kamenšek, Urška (Avtor)
ID Kranjc Brezar, Simona (Avtor)
ID Cör, Andrej (Avtor)
ID Serša, Gregor (Avtor)
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (978,26 KB)
MD5: 92B5D53995D5575313240A58D2D6CE45
 
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo OI - Onkološki inštitut Ljubljana
Povzetek:Background. Electrochemotherapy is a tumour ablation modality, based on electroporation of the cell membrane, allowing non-permeant anticancer drugs to enter the cell, thus augmenting their cytotoxicity by orders of magnitude. In preclinical studies, bleomycin and cisplatin proved to be the most suitable for clinical use. Intravenous administration of cisplatin for electrochemotherapy is still not widely accepted in the clinics, presumably due to its lower antitumor effectiveness, but adjuvant therapy by immunomodulatory or vascular-targeting agents could provide a way for its potentiation. Hence, the aim of the present study was to explore the possibility of adjuvant tumour necrosis factor % (TNF-%) therapy to potentiate antitumor effectiveness of electrochemotherapy with intravenous cisplatin administration in murine sarcoma. Materials and methods. In vivo study was designed to evaluate the effect of TNF-% applied before or after the electrochemotherapy and to evaluate the effect of adjuvant TNF-% on electrochemotherapy with different cisplatin doses. Results. A synergistic interaction between TNF-% and electrochemotherapy was observed. Administration of TNF-% before the electrochemotherapy resulted in longer tumour growth delay and increased tumour curability, and was significantly more effective than TNF-% administration after the electrochemotherapy. Tumour analysis revealed increased platinum content in tumours, TNF-% induced blood vessel damage and increased tumour necrosis after combination of TNF-% and electrochemotherapy, indicating an anti-vascular action of TNF-%. In addition, immunomodulatory effect might have contributed to curability rate of the tumours. Conclusion. Adjuvant intratumoural TNF-% therapy synergistically contributes to electrochemotherapy with intravenous cisplatin administration. Due to its potentiation at all doses of cisplatin, the combined treatment is predicted to be effective also in tumours, where the drug concentration is suboptimal or in bigger tumours, where electrochemotherapy with intravenous cisplatin is not expected to be sufficiently effective.
Ključne besede:electrochemotherapy, TNF, adjuvant immunotherapy, cisplatin
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Datum objave:01.03.2015
Založnik:Association of Radiology and Oncology
Leto izida:2015
Št. strani:str. 32-40, III
Številčenje:Vol. 49, no. 1
Izvor:Ljubljana
PID:20.500.12556/DiRROS-18726 Novo okno
UDK:602.6/.7
ISSN pri članku:1318-2099
DOI:10.1515/raon-2015-0005 Novo okno
COBISS.SI-ID:1975163 Novo okno
Avtorske pravice:by Authors
Datum objave v DiRROS:17.04.2024
Število ogledov:856
Število prenosov:212
Metapodatki:XML DC-XML DC-RDF
:
ČEMAŽAR, Maja, TODOROVIĆ, Vesna, ŠČANČAR, Janez, LAMPREHT TRATAR, Urša, SAVARIN, Monika, KAMENŠEK, Urška, KRANJC BREZAR, Simona, CÖR, Andrej in SERŠA, Gregor, 2015, Adjuvant TNF-a therapy to electrochemotherapy with intravenous cisplatin in murine sarcoma exerts synergistic antitumor effectiveness. Radiology and oncology [na spletu]. 2015. Vol. 49, no. 1, p. 32–40, iii. [Dostopano 2 april 2025]. DOI 10.1515/raon-2015-0005. Pridobljeno s: https://dirros.openscience.si/IzpisGradiva.php?lang=slv&id=18726
Kopiraj citat
  
Objavi na:Bookmark and Share



Podobna dela iz ostalih repozitorijev:

Ni podobnih del

Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Radiology and oncology
Skrajšan naslov:Radiol. oncol.
Založnik:Slovenian Medical Society - Section of Radiology, Croatian Medical Association - Croatian Society of Radiology
ISSN:1318-2099
COBISS.SI-ID:32649472 Novo okno

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:elektrokemoterapija, tumorski nekrotizirajoči faktor, intravenska elektrokemoterapija, dopolnilna imunska terapija


Nazaj